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Because of the presence of multiple proximal and distal 
sideholes, the autoperfusion balloon angioplasty catheter 
allows passive perfusion of blood through its central lumen 
while the balloon is inflated. This unique property can serve 
two major purposes. First, the catheter allows longer balloon 
inflation periods with less severe myocardial ischemia during 
routine coronary angioplasty. In animal and human studies 
(I ,2), the autoperfusion catheter led to significant ameliora- 
tion of ischemia during balloon inflations of at least 2 to 3 
min. Second, the catheter prevents myocardial necrosis 
during much longer periods of coronary occlusion that occur 
when coronary angioplasty is complicated by acute coronary 
thrombosis or severe coronary dissection. In this issue of the 
Journal. Campbell et al. (3) have shown that the autoperfu- 
sion balloon angioplasty catheter is effective in maintaining 
coronary flow and coronary hemodynamics and in prevent- 
ing the development of substantial necrosis during 90 min of 
circumflex coronary artery occlusion in dogs. 
Myocardial ischemia and injury during coronary angio- 
plasty. Profound myocardial dysfunction regularly accom- 
panies balloon inflation during coronary angioplasty (4,5). 
Several hemodynamic and mechanical variables are tran- 
siently, but markedly, disturbed during dilation. Within 20 s 
of the onset of balloon inflation, there is evidence of isch- 
emit regional left ventricular dysfunction, and frank akinesia 
and dyskinesia are present at 60 s after balloon inflation. 
With balloon deflation and consequent reperfusion, there is 
prompt recovery of regional function with restoration to 
preinfarction levels by 60 s. Thus, short periods of occlusion 
of a coronary artery during angioplasty in humans are well 
tolerated, and repeated short occlusions do not have a 
cumulative ischemic effect. 
In the experimental animal, reversibility of ischemic 
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changes is dependent on the duration of coronary occlusion. 
Following periods of occlusion of <2 min, myocardial func- 
tion recovers promptly and completely after reperfusion. 
With occlusions of r5 min, the myocardium is stunned and 
regional myocardial function may not return to preischemic 
levels until 6 h after reperfusion. Repeated 5-min episodes of 
ischemia may have a cumulative effect and result in areas of 
myocardial necrosis (6). 
Permanent coronary occlusions follow a highly predict- 
able pattern in dogs (7). However, after acute coronary 
thrombosis in humans, the time course and severity of 
ischemia vary among individuals because of much greater 
variation in preexisting collateral vessels. area of myocar- 
dium at risk and cardiac metabolic demands. 
Autoperfusion during routine coronary angioplasty. In his 
early animal experiments, Andreas R. Gruentzig used distal 
coronary perfusion with arterial blood through the dilation 
catheter during coronary angioplasty. However, he later 
abandoned this approach and did not use it or recommend its 
use in humans, thereby shedding some doubts on the value 
of this procedure during routine coronary angioplasty. 
Since its onset, the procedure of coronary angioplasty has 
been performed to achieve the best possible cosmetic result. 
The balloon is sized to the artery, and both undersizing and 
oversizing are avoided as much as possible because under- 
sizing frequently leads to an inadequate result and oversizing 
increases the risk of coronary artery dissection. No fixed 
rules exist concerning the amount of maximal pressure 
applied or the number and duration of balloon inflations. 
Inflation pressures vary from 2 to 12 atm, and there may not 
be any real advantage in increasing pressures beyond those 
that are necessary to suppress the central notch of the 
stenosis on the balloon catheter. Duration of inflations varies 
from 15 to 2120 s. depending on patient tolerance, i.e., 
severity of angina and electrocardiographic or blood pres- 
sure changes. After balloon deflation, the catheter is with- 
drawn and the guide is left in place. If the result appears 
inadequate. new balloon inflations are performed at higher 
pressures or with a larger balloon size. The final cosmetic 
result is assessed after withdrawal of the dilation system 
following repeat coronary angiography in the same projec- 
tions as before angioplasty. 
The potential use qf autoperfksion balloon angioplasty 
catheters during routine coronury ungioplast_v raises several 
qat~stions. Assuming that the autoperfusion catheter in- 
creases the patient tolerance to longer periods of balloon 
inflation. which is likely, there is still no conclusive evidence 
that longer inflation periods (up to 2 to 3 min) will increase 
the initial success rate of coronary angioplasty, influence the 
final cosmetic result or prevent late restenosis. Further 
studies are required to evaluate these hypotheses. On the 
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other hand, tolerance to balloon occlusion is highly variable 
among patients undergoing coronary angioplasty and is 
probably lowest in patients with severe or unstable angina, 
multivessel disease with large areas of myocardium at risk, 
limited collateral circulation and severe left ventricular dys- 
function from previous myocardial infarction. In these pa- 
tients, the autoperfusion catheter might enhance the com- 
fort, ease of performance and overall safety of the 
procedure. 
plasty can successfully reopen the vessel in some cases, 
particularly when a fresh thrombus is present. Finally, an 
obstructive coronary dissection can sometimes be tacked up 
by prolonged low pressure inflation of the balloon catheter. 
At present, tolerance to myocardial ischemia during 
coronary angioplasty is enhanced by intravenous or intra- 
coronary administration of nitroglycerin, calcium channel 
blockers and beta-blocking agents. Additional benefit from 
the use of the autoperfusion catheter will have to be dem- 
onstrated. Alternative methods will have to be evaluated and 
compared with the efficacy of the autoperfusion catheter, 
e.g., perfusion of arterial blood, hemoglobin derivatives and 
fluosol directly into the distal coronary artery or following 
diastolic retroperfusion in the coronary sinus, and coronary 
angioplasty using rapid intermittent systolic balloon infla- 
tions. 
The autoperfusion catheter could relieve angina and 
correct hemodynamic instability in patients requiring emer- 
gency coronary bypass surgery. The use of the catheter 
should not, however, unduly delay emergency bypass sur- 
gery. Progression to infarction depends on the duration of 
ischemia, and mortality and acute myocardial infarction are 
reduced when the intracorporeal circulation is begun soon 
after coronary occlusion. In patients undergoing emergency 
coronary bypass surgery, the incidence of acute myocardial 
infarction varies from 33% to 49%, postoperative complica- 
tions are much more frequent than after elective bypass 
surgery and postoperative mortality varies from 2% to 14% 
(9). Future studies will be needed to determine whether the 
autoperfusion catheter can decrease the incidence of emer- 
gency coronary bypass surgery and can reduce the risk of 
complications in patients undergoing emergency bypass sur- 
gery after a failed coronary angioplasty. 
Autoperfusion in patients with procedure-related com- 
plications. Abrupt coronary closure occurs in 3% to 5% of 
patients undergoing coronary angioplasty. This life- 
threatening complication results from a coronary thrombus, 
an occlusive coronary dissection, coronary spasm or, more 
frequently, a combination of these mechanisms. It is more 
frequent for lesions located in tortuous vessels, at bifurca- 
tion points or sharp bends, and for lesions that are long, 
heavily calcified or have an associated intraluminal throm- 
bus. However, it also occurs in uncomplicated coronary 
lesions. Administration of antiplatelet agents before and 
during angioplasty in association with intravenous heparin 
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